BioXcel Therapeutics, Inc. (BTAI) Covered Calls
There are no covered calls available for BioXcel Therapeutics, Inc..
Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
BioXcel Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on novel artificial intelligence-based drug development in the fields of neuroscience and immuno-oncology in the United States. The company is involved in developing BXCL501, a sublingual thin film formulation of dexmedetomidine for acute treatment of agitation resulting from neurological and psychiatric disorders; and BXCL701, an immuno-oncology agent for the treatment of prostate and pancreatic cancers, and other solid tumors. BioXcel Therapeutics, Inc. has a collaboration with Merck KGaA; Nektar Therapeutics, Inc.; and Pfizer Inc. to develop a therapy for treating pancreatic cancer. The company was founded in 2017 and is headquartered in New Haven, Connecticut. BioXcel Therapeutics, Inc. is a subsidiary of BioXcel Corporation.
| Top 10 Open Interest For May 16 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | IWM covered calls | 1. | STLA covered calls | |
| 2. | SPY covered calls | 7. | GLD covered calls | 2. | UPST covered calls | |
| 3. | TLT covered calls | 8. | FXI covered calls | 3. | NBIS covered calls | |
| 4. | SLV covered calls | 9. | TSLA covered calls | 4. | HOOD covered calls | |
| 5. | QQQ covered calls | 10. | INTC covered calls | 5. | RIOT covered calls | |
Want more examples? BSX Covered Calls | BTAL Covered Calls
